These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

304 related articles for article (PubMed ID: 25980482)

  • 21. Validation of ketamine as a pharmacological model of thalamic dysconnectivity across the illness course of schizophrenia.
    Abram SV; Roach BJ; Fryer SL; Calhoun VD; Preda A; van Erp TGM; Bustillo JR; Lim KO; Loewy RL; Stuart BK; Krystal JH; Ford JM; Mathalon DH
    Mol Psychiatry; 2022 May; 27(5):2448-2456. PubMed ID: 35422467
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The acute effects of NMDA antagonism: from the rodent to the human brain.
    Gunduz-Bruce H
    Brain Res Rev; 2009 May; 60(2):279-86. PubMed ID: 18703087
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ketamine effects on brain function--simultaneous fMRI/EEG during a visual oddball task.
    Musso F; Brinkmeyer J; Ecker D; London MK; Thieme G; Warbrick T; Wittsack HJ; Saleh A; Greb W; de Boer P; Winterer G
    Neuroimage; 2011 Sep; 58(2):508-25. PubMed ID: 21723949
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The effects of ketamine and risperidone on eye movement control in healthy volunteers.
    Schmechtig A; Lees J; Perkins A; Altavilla A; Craig KJ; Dawson GR; William Deakin JF; Dourish CT; Evans LH; Koychev I; Weaver K; Smallman R; Walters J; Wilkinson LS; Morris R; Williams SC; Ettinger U
    Transl Psychiatry; 2013 Dec; 3(12):e334. PubMed ID: 24326395
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of the effects of clozapine, risperidone, and olanzapine on ketamine-induced alterations in regional brain metabolism.
    Duncan GE; Miyamoto S; Leipzig JN; Lieberman JA
    J Pharmacol Exp Ther; 2000 Apr; 293(1):8-14. PubMed ID: 10734147
    [TBL] [Abstract][Full Text] [Related]  

  • 26. NMDA receptor antagonists traxoprodil and lanicemine improve hippocampal-prefrontal coupling and reward-related networks in rats.
    Becker R; Gass N; Kußmaul L; Schmid B; Scheuerer S; Schnell D; Dorner-Ciossek C; Weber-Fahr W; Sartorius A
    Psychopharmacology (Berl); 2019 Dec; 236(12):3451-3463. PubMed ID: 31267156
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Group II metabotropic glutamate receptor agonist prodrugs LY2979165 and LY2140023 attenuate the functional imaging response to ketamine in healthy subjects.
    Mehta MA; Schmechtig A; Kotoula V; McColm J; Jackson K; Brittain C; Tauscher-Wisniewski S; Kinon BJ; Morrison PD; Pollak T; Mant T; Williams SCR; Schwarz AJ
    Psychopharmacology (Berl); 2018 Jul; 235(7):1875-1886. PubMed ID: 29564482
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Alterations in interhemispheric gamma-band connectivity are related to the emergence of auditory verbal hallucinations in healthy subjects during NMDA-receptor blockade.
    Thiebes S; Steinmann S; Curic S; Polomac N; Andreou C; Eichler IC; Eichler L; Zöllner C; Gallinat J; Leicht G; Mulert C
    Neuropsychopharmacology; 2018 Jun; 43(7):1608-1615. PubMed ID: 29453445
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sensory transduction of weak electromagnetic fields: role of glutamate neurotransmission mediated by NMDA receptors.
    Frilot C; Carrubba S; Marino AA
    Neuroscience; 2014 Jan; 258():184-91. PubMed ID: 24239718
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of ketamine on brain function during response inhibition.
    Steffens M; Neumann C; Kasparbauer AM; Becker B; Weber B; Mehta MA; Hurlemann R; Ettinger U
    Psychopharmacology (Berl); 2018 Dec; 235(12):3559-3571. PubMed ID: 30357437
    [TBL] [Abstract][Full Text] [Related]  

  • 31. (R)- and (S)-ketamine induce differential fMRI responses in conscious rats.
    Masaki Y; Kashiwagi Y; Watabe H; Abe K
    Synapse; 2019 Dec; 73(12):e22126. PubMed ID: 31397936
    [TBL] [Abstract][Full Text] [Related]  

  • 32. NMDA receptor function and human cognition: the effects of ketamine in healthy volunteers.
    Malhotra AK; Pinals DA; Weingartner H; Sirocco K; Missar CD; Pickar D; Breier A
    Neuropsychopharmacology; 1996 May; 14(5):301-7. PubMed ID: 8703299
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Psychological effects of (S)-ketamine and N,N-dimethyltryptamine (DMT): a double-blind, cross-over study in healthy volunteers.
    Gouzoulis-Mayfrank E; Heekeren K; Neukirch A; Stoll M; Stock C; Obradovic M; Kovar KA
    Pharmacopsychiatry; 2005 Nov; 38(6):301-11. PubMed ID: 16342002
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Functional connectivity signatures of NMDAR dysfunction in schizophrenia-integrating findings from imaging genetics and pharmaco-fMRI.
    Gaebler AJ; Fakour N; Stöhr F; Zweerings J; Taebi A; Suslova M; Dukart J; Hipp JF; Adhikari BM; Kochunov P; Muthukumaraswamy SD; Forsyth A; Eggermann T; Kraft F; Kurth I; Paulzen M; Gründer G; Schneider F; Mathiak K
    Transl Psychiatry; 2023 Feb; 13(1):59. PubMed ID: 36797233
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of ketamine on brain function during smooth pursuit eye movements.
    Steffens M; Becker B; Neumann C; Kasparbauer AM; Meyhöfer I; Weber B; Mehta MA; Hurlemann R; Ettinger U
    Hum Brain Mapp; 2016 Nov; 37(11):4047-4060. PubMed ID: 27342447
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Glutamatergic Deficits in Schizophrenia - Biomarkers and Pharmacological Interventions within the Ketamine Model.
    Haaf M; Leicht G; Curic S; Mulert C
    Curr Pharm Biotechnol; 2018; 19(4):293-307. PubMed ID: 29929462
    [TBL] [Abstract][Full Text] [Related]  

  • 37. NMDA hypofunction in the posterior cingulate as a model for schizophrenia: an exploratory ketamine administration study in fMRI.
    Northoff G; Richter A; Bermpohl F; Grimm S; Martin E; Marcar VL; Wahl C; Hell D; Boeker H
    Schizophr Res; 2005 Jan; 72(2-3):235-48. PubMed ID: 15560968
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Altered functional brain network connectivity and glutamate system function in transgenic mice expressing truncated Disrupted-in-Schizophrenia 1.
    Dawson N; Kurihara M; Thomson DM; Winchester CL; McVie A; Hedde JR; Randall AD; Shen S; Seymour PA; Hughes ZA; Dunlop J; Brown JT; Brandon NJ; Morris BJ; Pratt JA
    Transl Psychiatry; 2015 May; 5(5):e569. PubMed ID: 25989143
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Regulation of neural responses to emotion perception by ketamine in individuals with treatment-resistant major depressive disorder.
    Murrough JW; Collins KA; Fields J; DeWilde KE; Phillips ML; Mathew SJ; Wong E; Tang CY; Charney DS; Iosifescu DV
    Transl Psychiatry; 2015 Feb; 5(2):e509. PubMed ID: 25689570
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Modulation of simultaneously collected hemodynamic and electrophysiological functional connectivity by ketamine and midazolam.
    Forsyth A; McMillan R; Campbell D; Malpas G; Maxwell E; Sleigh J; Dukart J; Hipp J; Muthukumaraswamy SD
    Hum Brain Mapp; 2020 Apr; 41(6):1472-1494. PubMed ID: 31808268
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.